| Schedule of Computation of Basic and Dilutive Net Loss Per Share |
The computation of basic and dilutive
net loss per share attributable to common stockholders for the three months ended March 31, 2025 and 2024, are as follows:
| |
|
Three Months ended
March 31, |
|
| |
|
2025 |
|
|
2024 |
|
| Basic: |
|
|
|
|
|
|
| Numerator: |
|
|
|
|
|
|
| Net income (loss) attributable to common shareholders |
|
$ |
4,299,052 |
|
|
$ |
(6,547,412 |
) |
| Denominator: |
|
|
|
|
|
|
|
|
| Weighted-average common shares outstanding |
|
|
36,369,224 |
|
|
|
21,115,617 |
|
| Net income (loss) per share – basic: |
|
$ |
0.12 |
|
|
$ |
(0.31 |
) |
| Diluted: |
|
|
|
|
|
|
|
|
| Numerator: |
|
|
|
|
|
|
|
|
| Net income (loss) attributable to common and common equivalent shareholders |
|
|
4,299,052 |
|
|
|
(6,547,412 |
) |
| Denominator: |
|
|
|
|
|
|
|
|
| Weighted-average common stock outstanding |
|
|
36,369,224 |
|
|
|
21,115,617 |
|
| Stock options, warrants, Earn-Out Liability, and convertible notes outstanding to purchase shares of common stock |
|
|
214,441 |
|
|
|
- |
|
| Total common and common equivalent shares outstanding |
|
|
36,583,665 |
|
|
|
21,115,617 |
|
| Net income (loss) per share – diluted: |
|
$ |
0.12 |
|
|
$ |
(0.31 |
) |
|
| Schedule of Net Income (Loss) Per Share-Diluted Including Anti-Dilutive |
The weighted average potential shares of common stock that were excluded
from the calculation of net income (loss) per share-diluted for the periods presented because including them would have been anti-dilutive
consisted of the following:
| | |
Three Months ended
March 31, | |
| | |
2025 | | |
2024 | |
| Stock options outstanding to purchase shares of common stock | |
| 4,145,706 | | |
| - | |
| Public and Private Warrants | |
| 11,799,851 | | |
| - | |
| Earn-Out Liability | |
| 4,500,000 | | |
| - | |
|